University of texas spore in lung cancer

Ended Project Grant Awarded Last action

Award ID
P50CA070907
Recipient
Awarding agency
Obligated
$55,339,383

Award facts

Assistance listing
93.397 Cancer Centers Support Grants
Completion date
Originally
Funding
  • $49,869,834.04 Federal
  • $5,469,549.27 Non-federal
Place of performance
Texas, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,188,505 $0
Amendment $2,188,505 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,110,656 $0
Amendment $2,110,656 $0
Amendment $118,034 $0
Amendment $118,034 $0
Amendment $2,110,656 $0
Amendment $118,034 $0
Amendment $45,613 $0
Amendment $45,613 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $45,613 $0
Amendment Targeting lung cancer vulnerabilities $45,613 $0
Amendment -$65,801 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… -$65,801 $0
Amendment Spore: developing new rationale, personalized medicine for lung cancer - description (provided by applicant): developing personalized medicine for lung… -$65,801 $0
Amendment Targeting lung cancer vulnerabilities -$65,801 $0
Amendment -$65,801 $0
Amendment $0 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $0 $0
Amendment Targeting lung cancer vulnerabilities $0 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $0 $0
Amendment Spore: developing new rationale, personalized medicine for lung cancer - description (provided by applicant): developing personalized medicine for lung… $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $0 $0
Amendment Spore: developing new rationale, personalized medicine for lung cancer - description (provided by applicant): developing personalized medicine for lung… $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $0 $0
Amendment $0 $0
Amendment Targeting lung cancer vulnerabilities $0 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $0 $0
Amendment Spore: developing new rationale, personalized medicine for lung cancer - description (provided by applicant): developing personalized medicine for lung… $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $45,593 $45,593
Amendment $45,593 $0
Amendment Targeting lung cancer vulnerabilities - overall spore summary/abstract targeting lung cancer vulnerabilities. The university of texas spore in lung cancer… $45,593 $0
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
The Univeristy Of Texas M.d. Anderson Cancer Center Assist Dr. Minna in identifying and understanding the molecular hallmarks of Lung cancer and translate information into the clinic for early detection,… $9,327,239
The Ohio State University Dr. Coombes will oversee all Core activities, coordinate biostatistics and bioinformatics support for the SPORE study. He will co-lead the monthly CORE… $67,749
The Univeristy Of Texas M.d. Anderson Cancer Center Supplemental funding to develop new patient-derived xenograft models from non-small lung cancer patients by rigorous quality standards and to facilitate… $1,056,488
University Of Texas At Dallas Test hypothesis that pharmacologically targeting HIF-1a/GLUT1 can be utilized as a targeted therapeutic strategy for lung SqCC. $50,000
The Univeristy Of Texas M.d. Anderson Cancer Center Assist Dr. Minna in identifying and understanding the molecular "hallmarks of Lung cancer" and translate information into the clinic for early detection,… $4,701,252
The Vanderbilt University $142,000
University Of Texas At Dallas We propose to find novel metabolites commonly accumulated in all or defined subtypes of NSCLC cell lines. We will employ gloval metabolite profiling of NSCLC… $38,250

Quick answers

Who received award P50CA070907?

P50CA070907 was awarded to The University Of Texas Southwestern Medical Center by National Cancer Institute (National Institutes of Health) on September 30, 1996.

How much is award P50CA070907 worth?

$55,339,383 has been obligated on P50CA070907: $49,869,834 in federal funding and $5,469,549 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login